DAMIANO, VINCENZO
DAMIANO, VINCENZO
Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer.
2005 Melisi, Davide; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Veneziani, BIANCA MARIA; Bianco, Ar; DE PLACIDO, Sabino; Ciardiello, F; Tortora, Giampaolo
Therapeutic integration of signal transduction targeting agents and conventional anti-cancer treatments.
2004 Melisi, Davide; Troiani, T; Damiano, Vincenzo; Tortora, Giampaolo; Ciardiello, F.
Combination of biological therapies in non-small cell lung cancer.
2006 Bianco, Roberto; Damiano, Vincenzo; Tortora, Giampaolo
Overexpression of wild-type p53 ovverrides the mitogenic effect of the RIa subunit of protein kinase A in human breast cells.
1995 Damiano, Vincenzo; F., Ciardiello; C., Bianco; G., Baldassarre; G., Di Isernia; Pepe, Stefano; A., Ruggiero; G., Merlo; Bianco, ANGELO RAFFAELE; Tortora, Giampaolo
Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotide targeting protein kinase A.
1997 Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Pepe, Stefano; Bianco, Ar; Jiang, Z; Agrawal, S; Ciardiello, F.
Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model.
2004 Raben, D; Bianco, C; Damiano, Vincenzo; Bianco, Roberto; Melisi, Davide; Mignogna, C; D'Armiento, FRANCESCO PAOLO; Cionini, L; Bianco, Ar; Tortora, Giampaolo; Ciardiello, F; Bunn, P.
Inhibition of growth factors production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
2001 Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo
Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity.
2001 Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Fontanini, G; Melisi, Davide; Veneziani, BIANCA MARIA; Zunino, F; Bianco, Ar; Ciardiello, F.
Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an EGFR-selective tyrosine kinase inhibitor.
2000 Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Pomatico, G; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo
A novel mdm2 antisense oligonucleotide has antitumor activity and potentiates cytotoxic drugs acting by different mechanisms in human colon cancer.
2000 Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Chen, J; Agrawal, S; Bianco, Ar; Ciardiello, F.
Combined blockade of PKA and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis.
2001 Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, F.
The RIalpha subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor. Oncogene. 1997 Feb 27;14(8):923-8.
1997 Tortora, Giampaolo; Damiano, Vincenzo; Bianco, C; Baldassarre, G; Bianco, Ar; Lanfrancone, L; Pelicci, Pg; Ciardiello, F.
A Novel Toll-Like Receptor 9 Agonist Cooperates with Trastuzumab in Trastuzumab-Resistant Breast Tumors through Multiple Mechanisms of Action
2009 Damiano, Vincenzo; Bianco, Roberto; Garofalo, Sonia; Rosa, Roberta; R., Caputo; Gelardi, Teresa; G., Merola; Racioppi, Luigi; Garbi, Corrado; Tortora, Giampaolo
Differential sensitivity to non-MHC-restricted rIL-2 activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or PKA subunits.
1996 Tagliaferri, P.; Tortora, Giampaolo; Guarrasi, R.; Damiano, Vincenzo; Ruggiero, A.; Morelli, D.; Caraglia, M.; Bianco, Roberto; di Isernia, G.; Pepe, Stefano; Arteaga, C. L.; Langton Webster, B. C.; Bianco, A. R.; Ciardiello, F.
Addition of erlotinib to fluoropyrimidine-oxaliplatin-basedchemotherapy with or without bevacizumab: Two sequential phase I trials
2011 Carlomagno, Chiara; Gennaro, Daniele*; Bianco, Roberto; Marciano, Roberta; Damiano, Vincenzo; Elide, Matano; Nappi, Lucia; Stefano, Pepe; DE PLACIDO, Sabino; Giampaolo, Tortora
Differential effects of type I and type II protein kinase A isoforms on chinese hamster ovary cell cycle and proliferation.
1994 Tortora, Giampaolo; Pepe, Stefano; Bianco, C.; Damiano, Vincenzo; Ruggiero, A.; Baldassarre, G.; Corbo, C.; Cho Chung, Y. S.; Bianco, A. R.; Ciardiello, F.
Cooperative antitumor effect of mixed backbone oligonucleotides targeting protein kinase A in combination with cytotoxic drugs or biologic agents.
1998 Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Pepe, Stefano; Pomatico, G; Bianco, Ar; Jiang, Z; Agrawal, S; Ciardiello, F.
Down-regulation of type I protein kinase A by transfection of human breast cancer cells with an epidermal growth factor receptor antisense expression vector.
1998 Ciardiello, F; Dixit, M; di Isernia, G; Damiano, Vincenzo; Bianco, Roberto; Bianco, Ar; Arteaga, Cl; Tortora, Giampaolo
The cAMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors.
1995 Tortora, Giampaolo; Ciardiello, F.; Damiano, Vincenzo; Pepe, Stefano; Bianco, C.; di Isernia, G.; Davies, S. L.; North, P.; Harris, A. L.; Hickson, I. D.; Bianco, A. R.
The mechanisms of resistance to EGFR inhibitors.
2007 Bianco, Roberto; Gelardi, Teresa; Damiano, Vincenzo; Tortora, Giampaolo
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer. | 1.1 Articolo in rivista | 2005 | Melisi, Davide; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Veneziani, BIANCA MARIA; Bianco, Ar; DE PLACIDO, Sabino; Ciardiello, F; Tortora, Giampaolo | |
| Therapeutic integration of signal transduction targeting agents and conventional anti-cancer treatments. | 1.1 Articolo in rivista | 2004 | Melisi, Davide; Troiani, T; Damiano, Vincenzo; Tortora, Giampaolo; Ciardiello, F. | |
| Combination of biological therapies in non-small cell lung cancer. | 1.1 Articolo in rivista | 2006 | Bianco, Roberto; Damiano, Vincenzo; Tortora, Giampaolo | |
| Overexpression of wild-type p53 ovverrides the mitogenic effect of the RIa subunit of protein kinase A in human breast cells. | 1.1 Articolo in rivista | 1995 | Damiano, Vincenzo; F., Ciardiello; C., Bianco; G., Baldassarre; G., Di Isernia; Pepe, Stefano; A., Ruggiero; G., Merlo; Bianco, ANGELO RAFFAELE; Tortora, Giampaolo | |
| Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotide targeting protein kinase A. | 1.1 Articolo in rivista | 1997 | Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Pepe, Stefano; Bianco, Ar; Jiang, Z; Agrawal, S; Ciardiello, F. | |
| Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model. | 1.1 Articolo in rivista | 2004 | Raben, D; Bianco, C; Damiano, Vincenzo; Bianco, Roberto; Melisi, Davide; Mignogna, C; D'Armiento, FRANCESCO PAOLO; Cionini, L; Bianco, Ar; Tortora, Giampaolo; Ciardiello, F; Bunn, P. | |
| Inhibition of growth factors production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. | 1.1 Articolo in rivista | 2001 | Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo | |
| Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity. | 1.1 Articolo in rivista | 2001 | Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Fontanini, G; Melisi, Davide; Veneziani, BIANCA MARIA; Zunino, F; Bianco, Ar; Ciardiello, F. | |
| Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an EGFR-selective tyrosine kinase inhibitor. | 1.1 Articolo in rivista | 2000 | Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Pomatico, G; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo | |
| A novel mdm2 antisense oligonucleotide has antitumor activity and potentiates cytotoxic drugs acting by different mechanisms in human colon cancer. | 1.1 Articolo in rivista | 2000 | Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Chen, J; Agrawal, S; Bianco, Ar; Ciardiello, F. | |
| Combined blockade of PKA and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis. | 1.1 Articolo in rivista | 2001 | Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, F. | |
| The RIalpha subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor. Oncogene. 1997 Feb 27;14(8):923-8. | 1.1 Articolo in rivista | 1997 | Tortora, Giampaolo; Damiano, Vincenzo; Bianco, C; Baldassarre, G; Bianco, Ar; Lanfrancone, L; Pelicci, Pg; Ciardiello, F. | |
| A Novel Toll-Like Receptor 9 Agonist Cooperates with Trastuzumab in Trastuzumab-Resistant Breast Tumors through Multiple Mechanisms of Action | 1.1 Articolo in rivista | 2009 | Damiano, Vincenzo; Bianco, Roberto; Garofalo, Sonia; Rosa, Roberta; R., Caputo; Gelardi, Teresa; G., Merola; Racioppi, Luigi; Garbi, Corrado; Tortora, Giampaolo | |
| Differential sensitivity to non-MHC-restricted rIL-2 activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or PKA subunits. | 1.1 Articolo in rivista | 1996 | Tagliaferri, P.; Tortora, Giampaolo; Guarrasi, R.; Damiano, Vincenzo; Ruggiero, A.; Morelli, D.; Caraglia, M.; Bianco, Roberto; di Isernia, G.; Pepe, Stefano; Arteaga, C. L.; Langton Webster, B. C.; Bianco, A. R.; Ciardiello, F. | |
| Addition of erlotinib to fluoropyrimidine-oxaliplatin-basedchemotherapy with or without bevacizumab: Two sequential phase I trials | 1.1 Articolo in rivista | 2011 | Carlomagno, Chiara; Gennaro, Daniele*; Bianco, Roberto; Marciano, Roberta; Damiano, Vincenzo; Elide, Matano; Nappi, Lucia; Stefano, Pepe; DE PLACIDO, Sabino; Giampaolo, Tortora | |
| Differential effects of type I and type II protein kinase A isoforms on chinese hamster ovary cell cycle and proliferation. | 1.1 Articolo in rivista | 1994 | Tortora, Giampaolo; Pepe, Stefano; Bianco, C.; Damiano, Vincenzo; Ruggiero, A.; Baldassarre, G.; Corbo, C.; Cho Chung, Y. S.; Bianco, A. R.; Ciardiello, F. | |
| Cooperative antitumor effect of mixed backbone oligonucleotides targeting protein kinase A in combination with cytotoxic drugs or biologic agents. | 1.1 Articolo in rivista | 1998 | Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Pepe, Stefano; Pomatico, G; Bianco, Ar; Jiang, Z; Agrawal, S; Ciardiello, F. | |
| Down-regulation of type I protein kinase A by transfection of human breast cancer cells with an epidermal growth factor receptor antisense expression vector. | 1.1 Articolo in rivista | 1998 | Ciardiello, F; Dixit, M; di Isernia, G; Damiano, Vincenzo; Bianco, Roberto; Bianco, Ar; Arteaga, Cl; Tortora, Giampaolo | |
| The cAMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors. | 1.1 Articolo in rivista | 1995 | Tortora, Giampaolo; Ciardiello, F.; Damiano, Vincenzo; Pepe, Stefano; Bianco, C.; di Isernia, G.; Davies, S. L.; North, P.; Harris, A. L.; Hickson, I. D.; Bianco, A. R. | |
| The mechanisms of resistance to EGFR inhibitors. | 1.1 Articolo in rivista | 2007 | Bianco, Roberto; Gelardi, Teresa; Damiano, Vincenzo; Tortora, Giampaolo |